Digital Library
Close Browse articles from a journal
 
<< previous    next >>
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
           All articles of the corresponding issues
                                       Details for article 14 of 25 found articles
 
 
  Irbesartan, an FDA approved drug for hypertension and diabetic nephropathy, is a potent inhibitor for hepatitis B virus entry by disturbing Na+-dependent taurocholate cotransporting polypeptide activity
 
 
Title: Irbesartan, an FDA approved drug for hypertension and diabetic nephropathy, is a potent inhibitor for hepatitis B virus entry by disturbing Na+-dependent taurocholate cotransporting polypeptide activity
Author: Wang, Xue-jun
Hu, Wei
Zhang, Ting-yu
Mao, Ying-ying
Liu, Nan-nan
Wang, Sheng-qi
Appeared in: Antiviral research
Paging: Volume 120 (2015) nr. C pages 7 p.
Year: 2015
Contents:
Publisher: Elsevier B.V.
Source file: Elektronische Wetenschappelijke Tijdschriften
 
 

                             Details for article 14 of 25 found articles
 
<< previous    next >>
 
 Koninklijke Bibliotheek - National Library of the Netherlands